Total Weight-Loss and Wellness Center operates as a physician-supervised telehealth practice serving patients throughout Memphis, TN and surrounding regions with a focused approach to medical weight management and metabolic optimization. The clinic structures its programs around FDA-approved GLP-1 receptor agonist therapies, combining pharmacological intervention with structured lifestyle modification protocols designed to address the underlying metabolic dysfunction that contributes to weight gain and obesity-related health complications. By delivering care through a telehealth platform, the practice eliminates geographic barriers for Tennessee residents seeking evidence-based weight loss treatment while maintaining the clinical oversight necessary for safe peptide therapy administration.
The clinic's treatment protocols center on three primary GLP-1 medications: liraglutide, semaglutide, and tirzepatide, each selected based on individual patient metabolic profiles, weight loss goals, and concurrent health conditions. Liraglutide therapy typically begins at 0.6 mg daily with gradual titration to therapeutic doses, offering patients a once-daily subcutaneous injection option with established cardiovascular benefits beyond weight reduction. Semaglutide protocols follow weekly dosing schedules starting at 0.25 mg with systematic increases to maintenance levels, providing enhanced glycemic control alongside appetite regulation for patients with type 2 diabetes or prediabetic conditions. Tirzepatide represents the clinic's dual GIP/GLP-1 receptor agonist option, prescribed for patients requiring more aggressive metabolic intervention, with dosing protocols that begin at 2.5 mg weekly and adjust based on tolerance and response metrics tracked through regular virtual check-ins.
The physician-supervised model at Total Weight-Loss and Wellness Center ensures that all peptide therapy prescriptions follow comprehensive medical evaluation protocols, including review of metabolic panels, thyroid function tests, and assessment of contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Providers conduct initial telehealth consultations that include detailed medical history review, current medication reconciliation, and discussion of realistic weight loss timelines based on starting BMI and metabolic health markers. Ongoing monitoring occurs through scheduled virtual appointments where providers assess treatment response, manage potential side effects such as nausea or gastrointestinal symptoms common during dose escalation phases, and adjust protocols based on patient-reported outcomes and objective weight loss data.
Patients enrolled in Total Weight-Loss and Wellness Center programs receive structured support that extends beyond peptide prescriptions to include nutritional guidance, behavioral modification strategies, and accountability systems designed to maximize treatment outcomes. The telehealth delivery model allows for flexible appointment scheduling that accommodates working professionals and individuals with mobility limitations, with video consultations conducted through HIPAA-compliant platforms that protect patient privacy while enabling face-to-face provider interaction. Medication fulfillment connects patients with partner pharmacies that ship directly to Memphis-area addresses, with providers coordinating prior authorization processes and insurance verification to minimize out-of-pocket costs for eligible patients.
The clinic's 5.0-star rating across 16 Google reviews reflects consistent patient satisfaction with both clinical outcomes and the accessibility of the telehealth care model, with patients reporting appreciation for the responsiveness of medical staff and the thoroughness of the initial evaluation process. Total Weight-Loss and Wellness Center differentiates itself in the Memphis metabolic health landscape by maintaining exclusive focus on physician-supervised GLP-1 therapy rather than diluting expertise across multiple wellness modalities, ensuring that providers remain current on emerging peptide research, dosing optimization strategies, and management protocols for the specific challenges that arise during long-term weight management treatment. This specialization allows the practice to refine patient selection criteria, identify candidates most likely to achieve sustained weight loss, and provide evidence-based guidance on transitioning from active weight loss phases to maintenance protocols that preserve metabolic improvements.
Dr. Miller, MD
Physician
Dr. Miller is a licensed physician providing physician-guided weight loss and metabolic health care aligned with recognized clinical guidelines. He received his medical degree from Columbia University and completed postgraduate training at Washington University in St. Louis. Dr. Miller conducts personalized medical evaluations and may prescribe treatment when appropriate.
Dr. Niles, MD
Physician
Dr. Niles is a licensed physician with over 30 years of clinical experience who provides physician-guided weight loss consultations centered on personalized care. She evaluates each patient’s medical history and individual goals to determine appropriate treatment options when indicated.
Dr. Krasne, MD
Physician
Dr. Krasne is a board-certified physician who conducts personalized weight loss evaluations and provides physician-guided care. He completed his medical training at the University of Florida and the University of Miami Miller School of Medicine, with residency completed in 2017. When clinically appropriate, he may prescribe GLP-1 medications based on individual health needs.
Dr. Bugailiskis, MD
Physician
Dr. Bugailiskis is a licensed physician who provides personalized, physician-guided weight loss care. She earned her medical degree from the University of Illinois at Chicago and works with patients to evaluate their health history, goals, and clinical needs when determining appropriate treatment options.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.
